Stephen N. Oesterle, M.D.
2529 Irving Avenue S, Minneapolis, MN 55405
email: [email protected]
work:
cell:
1-763-505-3020
1-612-747-4256
BIOGRAPHICAL SUMMARY
Stephen N. Oesterle, M.D., joined Medtronic in 2002 as Senior Vice President for Medicine and
Technology. In this role, Dr. Oesterle provides executive leadership for Medtronic scientific
research, formation of technological strategies and continued development of strong cooperative
relationships with the world's medical communities, technical universities, financial institutions
and emerging medical device companies.
Previously, Dr. Oesterle served as Associate Professor of Medicine at the Harvard University
Medical School and as Director of Invasive Cardiology Services at Massachusetts General
Hospital, Boston. A teacher and innovator in the field of cardiac catheterization, he has also
developed and directed interventional cardiology programs at Good Samaritan Hospital, Los
Angeles; at Georgetown University; and at Stanford University.
Dr. Oesterle is a 1973 summa cum laude graduate of Harvard College and received his medical
doctorate from Yale University in 1977. He completed his internship and residency at
Massachusetts General Hospital and also served a fellowship in interventional cardiology at
Stanford.
PROFESSIONAL EMPLOYMENT
MEDTRONIC, Inc. (2002-present)
Senior Vice President, Medicine & Technology
Corporate Leadership
 Executive Operating Committee member with shared responsibility for annual
operating plan, business development and long-term strategies.
 Quarterly business reviews for Medtronic’s $17B businesses including Cardiac
Rhythm Management, Coronary/Peripheral, Spine, Neuromodulation, Diabetes and
Surgical Technologies in all global markets.
 Global public spokesman for Medtronic technology and the future of medical devices
in improving patient outcomes.
Research Leadership
 Oversight and prioritization of Medtronic’s technology research & development
 Develop and lead collaborative relationships with technical universities, high
technology corporations and medical device startups
 Director, Medtronic Corporate Science and Technology Research Group (20022008). 150 member cross-functional team developing core technologies in material
science, polymers, and biological systems supporting all Medtronic businesses.
Stephen N. Oesterle, M.D.
MEDTRONIC (Continued)
External Board Leadership - Represent Medtronic in Over 20 Venture Investments:
Nanosys - Material Sciences, Display Technology, Quantum Dots
MicroChips, Microfabrica - MEMS Devices
Neoss (UK) - Dental Implants
MC10 - Flexible Microelectronics
REVA - Bioerodible polymers for coronary stents
Percutaneous Valve Technologies (Israel) - Transcatheter Cardiac Valves
HeartFlow, Cardiologic (Israel) - Diagnostics
PowerVision - Accommodating Intraocular Lens
GI Dynamics - Obesity/Diabetes
Mainstay Medical - Neuro Rehabilitation
Anulex - Interventional Spine
Advisor to International Medical Device Incubators
o MD Start (Switzerland)
o Rainbow Medical (Israel)
o TriVentures (Israel)
OTHER EXTERNAL ADVISORY ROLES

Venture Capital Advisor New Leaf Ventures, Polaris Partners

Academic Affiliations. Visiting Committee MIT Institute for Medical Engineering and
Science; MIT-Lemelson Prize Jury; Caltech Medical Engineering Advisory Committee;
Dean’s Advisory, Boston University School of Engineering
HARVARD MEDICAL SCHOOL, MASSACHUSETTS GENERAL HOSPITAL (1998-2002)
Associate Professor of Medicine, Director, Invasive Cardiology Services
 Director, Cardiac Device Development Laboratory
 Director, Center for Innovative Minimally Invasive Therapy (CIMIT)
Primary Concentration in real-time MRI compatible catheter based interventions

Co-Director, Fu Wai-MGH Heart Institute Collaboration, Beijing
Established training program for disseminating interventional cardiology skills
throughout China in conjunction with Boston Scientific Corporation


Consultant to major medical device companies and multiple medical device start-ups
Director, Tissue Engineering Laboratory for cardiovascular applications
STANFORD UNIVERSITY MEDICAL CENTER (1992-98)
Associate Professor of Medicine, Director, Cardiac Catheterization and Coronary
Intervention Laboratories
 Director, Interventional Cardiology Training Program
 Founder and Director of Stanford Interventional Device Development Laboratory
GEORGETOWN UNIVERSITY MEDICAL CENTER (1991-92)
Associate Professor of Medicine
Director, Cardiac Catheterization and Coronary Intervention Laboratories.
 Director, Cardiac Helicopter Transport Service
 Director Interventional Training Program
2
Stephen N. Oesterle, M.D.
GOOD SAMARITAN HOSPITAL, Los Angeles (1986-92)
Director, Cardiac Catheterization and Coronary Intervention Laboratories,
 Co-Founder The Heart Institute at Good Samaritan, Director Cardiac Device
Development Laboratory
 Established first helicopter based cardiac transport system in Los Angeles metro area
 Co-developed the largest referral cardiology practice in California
STANFORD UNIVERSITY MEDICAL CENTER (1981- 86)
Post Doctoral Fellow in Interventional Cardiology, Assistant Professor of Medicine,
Director, Unit for Coronary Interventions
SEQUOIA HOSPITAL, Redwood City, CA (1980-81)
Emergency Room Physician
HARVARD MEDICAL SCHOOL, MASSACHUSETTS GENERAL HOSPITAL (1977-1980)
Resident in Internal Medicine
ATOMIC BOMB CASUALTY COMMISSION, Hiroshima, Japan (1975-76)
Research Associate
EDUCATION
Yale University
Harvard University
Doctor of Medicine, cum laude
B.A. Chemistry, summa cum laude
1977
1973
Publications, Speaking Engagements and Academic Curriculum Vitae Available Upon Request
3